IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 238 filers reported holding IMMUNOGEN INC in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,695,737 | -20.5% | 1,871,187 | -5.5% | 0.01% | -14.3% |
| Q2 2023 | $37,352,372 | +639.1% | 1,979,458 | +50.4% | 0.01% | +600.0% |
| Q1 2023 | $5,053,885 | +27.2% | 1,316,116 | +64.3% | 0.00% | – |
| Q4 2022 | $3,973,139 | +7.4% | 801,036 | +3.5% | 0.00% | -100.0% |
| Q3 2022 | $3,698,000 | +92.2% | 773,839 | +81.0% | 0.00% | – |
| Q2 2022 | $1,924,000 | -27.6% | 427,517 | -23.4% | 0.00% | – |
| Q1 2022 | $2,658,000 | -77.6% | 558,285 | -65.1% | 0.00% | – |
| Q4 2021 | $11,870,000 | +127.4% | 1,599,612 | +73.8% | 0.00% | – |
| Q3 2021 | $5,220,000 | +45.4% | 920,621 | +69.0% | 0.00% | – |
| Q2 2021 | $3,591,000 | +2.5% | 544,847 | +25.9% | 0.00% | – |
| Q1 2021 | $3,504,000 | -45.0% | 432,677 | -56.2% | 0.00% | – |
| Q4 2020 | $6,376,000 | +448.2% | 988,622 | +205.8% | 0.00% | – |
| Q3 2020 | $1,163,000 | +3.9% | 323,308 | +33.0% | 0.00% | – |
| Q2 2020 | $1,119,000 | -26.9% | 243,131 | -45.8% | 0.00% | – |
| Q1 2020 | $1,530,000 | +12.9% | 448,841 | +69.1% | 0.00% | – |
| Q4 2019 | $1,355,000 | +8.7% | 265,425 | -48.5% | 0.00% | – |
| Q3 2019 | $1,246,000 | -86.8% | 515,209 | -88.2% | 0.00% | -100.0% |
| Q2 2019 | $9,458,000 | +40.3% | 4,358,921 | +75.2% | 0.00% | -66.7% |
| Q1 2019 | $6,743,000 | -5.3% | 2,488,258 | +67.7% | 0.00% | 0.0% |
| Q4 2018 | $7,123,000 | +305.4% | 1,483,797 | +699.5% | 0.00% | – |
| Q3 2018 | $1,757,000 | -78.1% | 185,600 | -77.5% | 0.00% | -100.0% |
| Q2 2018 | $8,035,000 | -17.2% | 825,774 | -10.5% | 0.00% | -25.0% |
| Q1 2018 | $9,708,000 | +421.9% | 922,800 | +218.0% | 0.00% | – |
| Q4 2017 | $1,860,000 | -55.3% | 290,200 | -46.7% | 0.00% | -100.0% |
| Q3 2017 | $4,163,000 | +35.9% | 544,109 | +26.3% | 0.00% | +100.0% |
| Q2 2017 | $3,063,000 | +187.9% | 430,900 | +56.7% | 0.00% | – |
| Q1 2017 | $1,064,000 | -27.1% | 275,000 | -61.6% | 0.00% | – |
| Q4 2016 | $1,459,000 | +154.6% | 715,384 | +234.3% | 0.00% | – |
| Q3 2016 | $573,000 | -3.0% | 213,984 | +11.7% | 0.00% | – |
| Q2 2016 | $591,000 | -79.0% | 191,600 | -42.1% | 0.00% | -100.0% |
| Q1 2016 | $2,820,000 | -27.7% | 330,991 | +15.2% | 0.00% | -50.0% |
| Q4 2015 | $3,900,000 | -0.4% | 287,384 | -29.6% | 0.00% | +100.0% |
| Q3 2015 | $3,917,000 | -33.2% | 407,972 | -0.0% | 0.00% | -66.7% |
| Q2 2015 | $5,867,000 | +104.9% | 408,076 | +27.5% | 0.00% | +200.0% |
| Q1 2015 | $2,864,000 | -31.7% | 320,096 | -53.4% | 0.00% | 0.0% |
| Q4 2014 | $4,191,000 | +44.8% | 687,076 | +151.4% | 0.00% | – |
| Q3 2014 | $2,894,000 | -36.5% | 273,276 | -28.9% | 0.00% | -100.0% |
| Q2 2014 | $4,557,000 | -34.3% | 384,612 | -17.2% | 0.00% | 0.0% |
| Q1 2014 | $6,931,000 | -8.9% | 464,254 | -10.5% | 0.00% | -25.0% |
| Q4 2013 | $7,607,000 | -18.0% | 518,596 | -4.8% | 0.00% | -20.0% |
| Q3 2013 | $9,275,000 | +16.8% | 544,908 | +13.8% | 0.01% | +25.0% |
| Q2 2013 | $7,941,000 | – | 478,670 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| QVT Financial LP | 1,375,900 | $6,329,000 | 1.08% |
| Redmile Group, LLC | 12,006,979 | $55,232,000 | 1.02% |
| Birchview Capital, LP | 190,000 | $874,000 | 0.53% |
| Fernwood Investment Management, LLC | 179,340 | $825,000 | 0.41% |
| HealthCor Management, L.P. | 1,200,000 | $5,520,000 | 0.23% |
| Grace Capital | 49,500 | $228,000 | 0.20% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $479,000 | 0.19% |
| Virtus ETF Advisers LLC | 79,795 | $367,000 | 0.17% |
| PINNACLE ASSOCIATES LTD | 1,087,034 | $5,000,000 | 0.12% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 100,000 | $460,000 | 0.12% |